Company profile
Brainstorm Cell Therapeutics
- Industry
- Biotechnology Research
- Employees
- 29
- Headquarters
- Kiryat Aryeh, Petach Tikva
- Founded
- 2004
- LinkedIn followers
- 7,283
- Office locations
- 2
Brainstorm Cell Therapeutics company summary
Brainstorm Cell Therapeutics is a company in the Biotechnology Research industry, headquartered in Kiryat Aryeh, Petach Tikva, founded in 2004. On LinkedIn the company has around 29 employees and 7,283 followers. The company lists 2 office locations. Its listed specialties include stem cell therapy, drug development, neurodegenerative diseases, ALS.
What technology does Brainstorm Cell Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Brainstorm Cell Therapeutics
BrainStorm Cell Therapeutics Inc. (NASDAQ) develops autologous stem cell therapies for neurodegenerative disorders such as ALS, MS, and Parkinson’s disease. These diseases have limited treatment options and represent unmet medical needs. NurOwn® is BrainStorm’s proprietary process for differentiating autologous mesenchymal stem cells (MSC) into neurotrophic factor (NTF)-secreting cells, transplanted at or near the affected tissue site. Our technology converts MSCs into a living drug delivery system for NTFs. We have proof-of-concept in various animal models of neurodegenerative diseases, including Parkinson's, Huntington's, ALS, MS, and peripheral nerve injury. We have completed two single-arm clinical trials in ALS patients in Israel, demonstrating good safety and tolerability profiles and strong efficacy signals. We also finalized a Phase 3 randomized, double-blind, placebo-controlled clinical trial at multiple US sites, supported by a $16 million USD grant from the California Institute for Regenerative Medicine (CIRM) and another grant from the ALS Association. Currently, we are planning a Phase 3b clinical trial of NurOwn® in ALS under a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA). For more information, visit www.brainstorm-cell.com
Specialties
Where is Brainstorm Cell Therapeutics located?
Brainstorm Cell Therapeutics lists 2 office locations.
Compare companies similar to Brainstorm Cell Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Brainstorm Cell Therapeutics brainstorm-cell.com | Biotechnology Research | 29 | 2004 | Kiryat Aryeh, Petach Tikva |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Brainstorm Cell Therapeutics
What does Brainstorm Cell Therapeutics do?
BrainStorm Cell Therapeutics Inc. (NASDAQ) develops autologous stem cell therapies for neurodegenerative disorders such as ALS, MS, and Parkinson’s disease. These diseases have limited treatment options and represent unmet medical needs. NurOwn® is BrainStorm’s proprietary process for differentiating autologous mesenchymal stem cells (MSC) into neurotrophic factor (NTF)-secreting cells, transplanted at or near the affected tissue site. Our technology converts MSCs into a living drug delivery system for NTFs. We have proof-of-concept in various animal models of neurodegenerative diseases, including Parkinson's, Huntington's, ALS, MS, and peripheral nerve injury. We have completed two single-arm clinical trials in ALS patients in Israel, demonstrating good safety and tolerability profiles and strong efficacy signals. We also finalized a Phase 3 randomized, double-blind, placebo-controlled clinical trial at multiple US sites, supported by a $16 million USD grant from the California Institute for Regenerative Medicine (CIRM) and another grant from the ALS Association. Currently, we are planning a Phase 3b clinical trial of NurOwn® in ALS under a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA). For more information, visit www.brainstorm-cell.com
How many employees does Brainstorm Cell Therapeutics have?
Brainstorm Cell Therapeutics has around 29 employees on LinkedIn.
Where is Brainstorm Cell Therapeutics headquartered?
Brainstorm Cell Therapeutics is headquartered in Kiryat Aryeh, Petach Tikva.
Where does Brainstorm Cell Therapeutics have offices?
Brainstorm Cell Therapeutics lists 2 office locations, including Kiryat Aryeh, Petach Tikva, IL; Hackensack, NJ, US.
When was Brainstorm Cell Therapeutics founded?
Brainstorm Cell Therapeutics was founded in 2004.
Build a lead list from companies like Brainstorm Cell Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.